Skye Bioscience Inc
Change company Symbol lookup
Select an option...
SKYE Skye Bioscience Inc
FRME First Merchants Corp
SFDMY Shanghai Fudan Microelectronics Group Co Ltd
NWL Newell Brands Inc
MRK Merck & Co Inc
FWONA Liberty Media Corp
RSG Republic Services Inc
TENB Tenable Holdings Inc
NLSN Nielsen Holdings PLC
CLAR Clarus Corp

Health Care : Biotechnology |
Company profile

Skye Bioscience, Inc., formerly Emerald Bioscience, Inc., is a biopharmaceutical company, which is engaged in engineering cannabinoid derivatives to treat glaucoma and other diseases. The Company is focused on discovery, development, and commercialization of cannabinoid-derived therapeutics, with clinical and commercial differentiation for the treatment of glaucoma diseases. Its programs include THCVHS and CBDVHS. The Company's lead candidate, THCVHS, a prodrug of tetrahydrocannabinol (THC), is a topical formulation under development for the treatment of glaucoma and ocular hypertension (OHT). It chemically modifies THC to create a unique synthetic molecule with the intent to realize the known positive effects of THC. CBDVHS is a prodrug of cannabidiol (CBD) that has demonstrated biological activity in prodrug form (CBDVHS) and as native (natural) CBD. The Company has chemically-modified the CBD molecule to improve on its known positive effects.

Closing Price
Day's Change
0.0027 (4.54%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

Earnings information for SKYE is not available.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Information provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.